Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Jonathan D Tward"'
Publikováno v:
Radiation, Vol 4, Iss 2, Pp 142-148 (2024)
PET/CT scans are being used to assess patients who have experienced biochemical failure following surgery or radiation therapy for localized prostate cancer. We aimed to evaluate the language used in report impressions and to determine the level of c
Externí odkaz:
https://doaj.org/article/cdb49265762e4bfe882e3adedcce674b
Autor:
Matthew W. Parsons, Calvin Rock, Jonathan J. Chipman, Harsh R. Shah, Boyu Hu, Deborah M. Stephens, Randa Tao, Jonathan D. Tward, David K. Gaffney
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2624-2636 (2023)
Abstract Background Survivors of non‐Hodgkin lymphoma (NHL) have increased secondary malignancy (SM) risk. We quantified this risk by patient and treatment factors. Methods Standardized incidence ratios (SIR, observed‐to‐expected [O/E] ratio) w
Externí odkaz:
https://doaj.org/article/4af0069187fe4b81b7b85ec82949b121
Autor:
Calvin B. Rock, MD, Jonathan J. Chipman, PhD, Matthew W. Parsons, MD, Chris R. Weil, MD, Ryan J. Hutten, MD, Randa Tao, MD, Jonathan D. Tward, MD, PhD, Harsh R. Shah, DO, Boyu Hu, MD, Deborah M. Stephens, DO, David K. Gaffney, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101035- (2022)
Purpose: Previous studies have shown an increased risk of second primary malignancies (SPMs) in survivors of diffuse large B-cell lymphoma (DLBCL). Survivors live longer due to the intensification of and improvements in therapy; thus, we aimed to cha
Externí odkaz:
https://doaj.org/article/20ba651be27a4d15b7ee95d09117407d
Publikováno v:
European Urology Open Science, Vol 23, Iss , Pp 30-33 (2021)
Primary squamous cell carcinoma is a rare, aggressive disease with historically poor outcomes and no established treatment guidelines. Case reports are limited but describe multiple treatment approaches. Seeking to identify practice patterns and trea
Externí odkaz:
https://doaj.org/article/c1ed235675204e539efa4df917e721e8
Autor:
Ryan D. Kraus, MD, Christopher R. Weil, MD, MS, Stacey Wells, MD, Jonathan D. Tward, MD, PhD, John S. Groundland, MD, MS, Kevin B. Jones, MD, Donald M. Cannon, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100795- (2022)
Purpose: Patients who undergo surgical stabilization for impending or pathologic fractures secondary to metastasis are often treated with radiation therapy to the involved site. We sought to retrospectively analyze outcomes from single versus multifr
Externí odkaz:
https://doaj.org/article/6389d6f6b69f4470904f9e21d65dca7f
Autor:
Sagar A. Patel, Ting Martin Ma, Jessica K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar, Chandana Reddy, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Phuoc T. Tran, Daniel J. Krauss, Eyad I. Abu-Isa, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Theodore L. DeWeese, Derya Tilki, Jay P. Ciezki, R. Jeffrey Karnes, Nicholas G. Nickols, Matthew B. Rettig, Felix Y. Feng, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Paul C. Boutros, Tahmineh Romero, Eric M. Horwitz, Rahul D. Tendulkar, Michael L. Steinberg, Daniel E. Spratt, Michael Xiang, Amar U. Kishan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:645-653
Very-high-risk (VHR) prostate cancer (PC) is an aggressive subgroup with high risk of distant disease progression. Systemic treatment intensification with abiraterone or docetaxel reduces PC-specific mortality (PCSM) and distant metastasis (DM) in me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13301f04ee3b29c70d7c09ab1809fdab
https://doi.org/10.1016/j.ijrobp.2022.09.075
https://doi.org/10.1016/j.ijrobp.2022.09.075
Publikováno v:
Prostate Cancer, Vol 2020 (2020)
Purpose. To investigate how pretreatment testosterone levels correlate with progression-free survival, metastasis-free survival, and overall survival in a propensity-adjusted localized prostate cancer population. Methods. Men diagnosed with clinical
Externí odkaz:
https://doaj.org/article/f99f897f963444639fdb8904e2d4fa60
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 2, Pp 170-180 (2018)
Purpose: The aim of this study is to describe the trends and factors that influence the initial treatment of men with localized prostate cancer (PC) in the United States between 2004 and 2014. Methods and materials: The National Cancer Institute's Su
Externí odkaz:
https://doaj.org/article/ab84c54bc1db4e4bb82f1619ca5f4b02
Autor:
Victor J. Gonzalez, MD, Craig R. Hullett, MD, PhD, Lindsay Burt, MD, Prema Rassiah-Szegedi, PhD, Vikren Sarkar, PhD, Jonathan D. Tward, MD, PhD, Lisa J. Hazard, MD, Y. Jessica Huang, PhD, Bill J. Salter, PhD, David K. Gaffney, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 2, Pp 235-243 (2017)
Purpose: To report the results of a prospective study that compares small bowel doses during prone and supine pelvic intensity modulated radiation therapy. Methods and materials: Ten patients receiving pelvic radiation therapy each had 2 intensity mo
Externí odkaz:
https://doaj.org/article/ecfba017364c49298d49898d680d1595
Autor:
Matthew W. Parsons, Calvin Rock, Jonathan J. Chipman, Harsh R. Shah, Boyu Hu, Deborah M. Stephens, Randa Tao, Jonathan D. Tward, David K. Gaffney
Publikováno v:
Cancer Medicine. 12:2624-2636
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b80073b6d997931e9216b141fea411b
https://doi.org/10.1002/cam4.5139
https://doi.org/10.1002/cam4.5139